Dongze Zhang

Jiangsu Key Laboratory Of Clinical Immunology
Suzhou, 215000, China

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications

EOAI3402143 inhibits lung adenocarcinoma progression through the NF-κB/NR4A1 pathway.

EOAI3402143 inhibits lung adenocarcinoma progression through the NF-κB/NR4A1 pathway.

Journal: Acta biochimica et biophysica Sinica
Published: October 11, 2025

HKI-357 inhibits castration-resistant prostate cancer by targeting UBE2C via the AKT signaling pathway.

HKI-357 inhibits castration-resistant prostate cancer by targeting UBE2C via the AKT signaling pathway.

Journal: Biochemical pharmacology
Published: June 15, 2025

TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion.

TRIM32 promotes anoikis resistance and metastasis in NSCLC by degrading CHEK2 to enhance IL-6 secretion.

Journal: Cell death and differentiation
Published: January 27, 2025

Discovery of a novel BCL-2 inhibitor GW806742X for the treatment of TNBC.

Discovery of a novel BCL-2 inhibitor GW806742X for the treatment of TNBC.

Journal: Biochemical pharmacology
Published: October 16, 2024

High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis.

High expression of B7-H3 on monocyte/macrophages in tumor microenvironment promotes lung cancer progression by inhibiting apoptosis.

Journal: Translational oncology
Published: October 16, 2023

Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.

Pharmacological suppression of HHLA2 glycosylation restores anti-tumor immunity in colorectal cancer.

Journal: Cancer letters
Published: August 25, 2023

B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer.

B7H3 increases ferroptosis resistance by inhibiting cholesterol metabolism in colorectal cancer.

Journal: Cancer science
Published: April 24, 2023

TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer through ubiquitin‒proteasome-mediated degradation of PRKCD.

TRIM69 suppressed the anoikis resistance and metastasis of gastric cancer through ubiquitin‒proteasome-mediated degradation of PRKCD.

Journal: Oncogene
Published: April 04, 2023

Fibronectin enhances tumor metastasis through B7-H3 in clear cell renal cell carcinoma.

Fibronectin enhances tumor metastasis through B7-H3 in clear cell renal cell carcinoma.

Journal: FEBS open bio
Published: February 28, 2021

B7-H3 inhibits apoptosis of gastric cancer cell by interacting with Fibronectin.

B7-H3 inhibits apoptosis of gastric cancer cell by interacting with Fibronectin.

Journal: Journal of Cancer
Published: February 09, 2021

Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.

Nomograms-based prediction of overall and cancer-specific survivals for patients with chromophobe renal cell carcinoma.

Journal: Experimental biology and medicine (Maywood, N.J.)
Published: December 11, 2020

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway.

Metformin exerts anti-AR-negative prostate cancer activity via AMPK/autophagy signaling pathway.

Journal: Cancer cell international
Published: May 20, 2020
Showing 1-12 of 13

Last Updated: 09/26/2026